Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Braz. j. med. biol. res ; 45(2): 97-103, Feb. 2012. ilus, tab
Artigo em Inglês | LILACS | ID: lil-614568

RESUMO

The biological functions of the BC047440 gene highly expressed by hepatocellular carcinoma (HCC) are unknown. The objective of this study was to reconstruct antisense eukaryotic expression vectors of the gene for inhibiting HepG2 cell proliferation and suppressing their xenograft tumorigenicity. The full-length BC047440 cDNA was cloned from human primary HCC by RT-PCR. BC047440 gene fragments were ligated with pMD18-T simple vectors and subsequent pcDNA3.1(+) plasmids to construct the recombinant antisense eukaryotic vector pcDNA3.1(+)BC047440AS. The endogenous BC047440 mRNA abundance in target gene-transfected, vector-transfected and naive HepG2 cells was semiquantitatively analyzed by RT-PCR and cell proliferation was measured by the MTT assay. Cell cycle distribution and apoptosis were profiled by flow cytometry. The in vivo xenograft experiment was performed on nude mice to examine the effects of antisense vector on tumorigenicity. BC047440 cDNA fragments were reversely inserted into pcDNA3.1(+) plasmids. The antisense vector significantly reduced the endogenous BC047440 mRNA abundance by 41 percent in HepG2 cells and inhibited their proliferation in vitro (P < 0.01). More cells were arrested by the antisense vector at the G1 phase in an apoptosis-independent manner (P = 0.014). Additionally, transfection with pcDNA3.1(+)BC047440AS significantly reduced the xenograft tumorigenicity in nude mice. As a novel cell cycle regulator associated with HCC, the BC047440 gene was involved in cell proliferation in vitro and xenograft tumorigenicity in vivo through apoptosis-independent mechanisms.


Assuntos
Animais , Humanos , Camundongos , Carcinoma Hepatocelular/metabolismo , DNA Antissenso/genética , Expressão Gênica , Vetores Genéticos/genética , Proliferação de Células , DNA Antissenso/metabolismo , Células Eucarióticas/metabolismo , Citometria de Fluxo , Vetores Genéticos/metabolismo , /metabolismo , Camundongos Nus , Transplante de Neoplasias , Plasmídeos/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , RNA Mensageiro/análise , Transfecção , Ensaios Antitumorais Modelo de Xenoenxerto
2.
Medicina (B.Aires) ; 56(1): 51-4, ene.-feb. 1996. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-163385

RESUMO

En un estudio previo demostramos que líneas celulares y tumores de melanoma humano expresan altos niveles de la proteína de matriz extracelular SPARC. Para determinar su rol en la progresión del melanoma humano, la línea IIB-MELLES fue transfectada con el cDNA de SPARC anti-sentido. Se aislaron tres clones con expresión disminuida de SPARC. Ninguno de ellos mostró cambios en la cinética de crecimiento in vitro comparado con las células control. La inyección s.c. de células control en ratones atímicos mostró desarrollo tumoral en el 100 por ciento de los animales, mientras que ninguno de los clones dio origen a tumores. Estos estudios demuestran que SPARC podría jugar un rol central en la progresión del melanoma humano.


Assuntos
Animais , Masculino , Camundongos , Humanos , Melanoma/patologia , Osteonectina/fisiologia , Northern Blotting , Western Blotting , Células Clonais , DNA Antissenso/genética , Melanoma/metabolismo , Camundongos Endogâmicos BALB C , Osteonectina/metabolismo , Ratos Nus , Fatores de Tempo , Células Tumorais Cultivadas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA